Frees Fund is a venture capital firm primarily focused on early-stage investments, while also engaging in growth and mid-to-late stage opportunities. Their strategy involves identifying unique interdisciplinary opportunities and future-oriented trends across core sectors like consumer/TMT, high technology, and biomedicine, with an emphasis on technological innovation and social impact.
50% of their portfolio is in Biotech & Life Sciences. They made 1 investments in the last 12 months. Their most common stage is series-a (50% of deals).
Portfolio
2
Fund Size
$2B
Top Stage
Series A
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
2 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| RRezubio | Series A | $20M | Dec 2025 |
| UUnity Technologies | Series C | $181M | Jul 2016 |
Top Co-Investors
Last updated: 28 April 2026